Screener
Natera, Inc. NTRA Testing and laboratory materials from suppliers
Testing and laboratory materials from suppliers at other companies
Other financials
Where this comes from
Reported directly by Natera, Inc. in its filing.
Tagged under the XBRL concept ntra:AccruedTestingAndLaboratoryMaterialsFromSuppliers.
The source filing: Natera, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054525
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Legal, audit and consulting fees | $53,808 | $56,077 |
| Testing and laboratory materials from suppliers | 30,917 | 12,353 |
| Clinical trials and studies | 28,442 | 14,467 |
| Marketing and corporate affairs | 26,242 | 20,215 |
| Property and equipment purchases | 20,458 | 11,270 |
| Accrued charges for third-party testing | 18,427 | 20,874 |
| Operating lease liabilities, current portion | 15,123 | 15,581 |
| Accrued third-party service fees | 10,287 | 9,758 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Natera, Inc.'s testing and laboratory materials from suppliers?
- Natera, Inc. (NTRA) reported testing and laboratory materials from suppliers of $30.92M in Q2 2026.
- What does testing and laboratory materials from suppliers mean?
- Testing and laboratory materials from suppliers as reported by Natera, Inc. Common Stock.
Ask your AI about Natera, Inc.'s testing and laboratory materials from suppliers.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude